Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

Forty percent of non-small cell lung cancer (NSCLC) patients develop brain metastases, resulting in a dismal prognosis. However, patients in an oligo-metastatic brain disease setting seem to have better outcomes. Here, we investigate the possibility of using circulating tumor cells (CTCs) as biomark...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Hanssen, Annkathrin, Riebensahm, Carlotta, Mohme, Malte, Joosse, Simon A., Velthaus, Janna-Lisa, Berger, Lars Arne, Bernreuther, Christian, Glatzel, Markus, Loges, Sonja, Lamszus, Katrin, Westphal, Manfred, Riethdorf, Sabine, Pantel, Klaus, Wikman, Harriet
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6315958/
https://ncbi.nlm.nih.gov/pubmed/30572662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10120527
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars